Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic
Muller Fabbri1, George A Calin2, Carlo M Croce3
1Center for Cancer and Immunology Research, Children's National Hospital, and George Washington University, Washington, DC.
JAMA
|June 9, 2025
Abstract
No abstract available in PubMed .
More Related Videos
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.6K
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.7K
